得宝松穴位注射治疗角化过度型湿疹临床研究  

Clinical study on treating eczema of hyperkeratosis type by point injection of diprospan

作　　者：王玉梅[1] Wang Yumei

机构地区：[1]安岳县中医医院,四川安岳642350

出　　处：《中医临床研究》2019年第5期124-126,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨得宝松注射液治疗角化过度型湿疹的临床疗效。方法:选取我院2016年6月-2015年6月收治的128例角化过度型湿疹患者作为研究对象,随机分为治疗组64例和对照组64例,治疗组采用得宝松注射液穴位注射治疗,对照组采用卤米松乳膏外用治疗。比较两组患者的疗效差异及不良反应发生情况。结果:对照组总有效率为84.38%,治疗组的总有效率大约为96.87%,差异有统计学意义(P <0.05)。对照组不良反应发生率为7.81%,治疗组不良反应发生率为6.25%。两组比较差异无统计学意义(P> 0.05)。结论:得宝松注射液穴位注射治疗角化过度型湿疹是一种安全有效的方法,值得推广。Objective: To investigate clinical efficacy of point injection of diprospan on eczema of hyperkeratosis type. Methods: 128 cases were divided into 2 groups, 64 cases in each. The control group was given halometasone;and the treatment group was given point injection of diprospan. Results: The total efficiency in the control group was 84.38%, and that in the treatment group was 96.87%( P <0.05). The incidence of adverse reactions was 7.81% in the control group and 6.25% in the treatment group ( P >0.05). Conclusion: Point injection of diprospan on eczema of hyperkeratosis type show a good effect, and is worthy of promotion.

关 键 词：得宝松注射液 穴位注射 角化过度型湿疹 

分 类 号：R758.23[医药卫生—皮肤病学与性病学]